A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1

Sponsor
Mayo Clinic (Other)
Overall Status
Enrolling by invitation
CT.gov ID
NCT01898637
Collaborator
(none)
1,500
1
2
126.9
11.8

Study Details

Study Description

Brief Summary

The goal of this project is to determine if the change in oxygen saturation during deep inspiration ("augmented pulse oximetry") can be used as a method to rule out pulmonary embolism (PE). The investigators propose to evaluate a simple, non-invasive clinical tool to help rule out PE. The investigators plan to measure the oxygen saturation of 40 consecutive patients with newly-diagnosed PE (within 60 minutes of diagnosis) and 80 matched controls who do not have a PE. Trained, blinded Respiratory Therapists or Study Coordinators will record each patient's oxygen saturation before, during, and after a 2-minute period of deep inspirations (vital capacity [the maximal amount of air that can be inhaled, measured in milliliters]) using an incentive spirometer. The investigators' central hypothesis is that persons with a PE will not respond to augmented pulse oximetry and will not significantly improve or normalize their oxygen saturation.

Condition or Disease Intervention/Treatment Phase
  • Other: Augmented pulse oximetry using incentive spirometer.
  • Device: Incentive spirometer.
N/A

Detailed Description

Patients will be identified and enrolled by the Mayo Clinic St. Marys Emergency Department staff as they are undergoing medical care in the Emergency Department.

The investigators will calculate the difference in oxygen saturation pre- and post-deep inspiration (ΔSpO2 at 1 minute, 2 minutes and 4 minutes), and then correlate these values with the CT result.

In cases of PE, The investigators expect the SpO2 to remain unchanged, or to change less than 3-5%. The investigators expect alternate hypoxemic conditions to have a significantly greater increase in SpO2.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
1500 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Care Provider)
Primary Purpose:
Diagnostic
Official Title:
A Simple Clinical Tool to Help Diagnose Pulmonary Embolism: Phase 1
Study Start Date :
Jun 1, 2013
Anticipated Primary Completion Date :
Dec 30, 2023
Anticipated Study Completion Date :
Dec 30, 2023

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Proven pulmonary embolism.

Augmented pulse oximetry using incentive spirometer. Emergency Department patients with pulmonary embolism.

Other: Augmented pulse oximetry using incentive spirometer.
Augmented pulse oximetry using incentive spirometer.

Device: Incentive spirometer.
The incentive spirometer is a simple passive device that measures the amount of air a person can inhale.
Other Names:
  • AirLife Volumetric Incentive Spirometer.
  • Other: Control patients

    Augmented pulse oximetry using incentive spirometer. Emergency Department patients who do not have pulmonary embolism.

    Other: Augmented pulse oximetry using incentive spirometer.
    Augmented pulse oximetry using incentive spirometer.

    Device: Incentive spirometer.
    The incentive spirometer is a simple passive device that measures the amount of air a person can inhale.
    Other Names:
  • AirLife Volumetric Incentive Spirometer.
  • Outcome Measures

    Primary Outcome Measures

    1. Change in oxygen saturation using augmented pulse oximetry for patients with and without pulmonary embolism. [Oxygen saturation (SpO2) will be recorded prior to using the spirometer, at 1 minute (during use of the spirometer), at 2 minutes (at the end of using the spirometer), and at 4 minutes.]

      Trained, blinded Respiratory Therapists or Study Coordinators will record each patient's oxygen saturation before, during, and after a 2-minute period of deep inspirations (vital capacity) using an incentive spirometer. The investigators will calculate the difference in oxygen saturation pre- and post-deep inspiration (ΔSpO2 at 1 minute, 2 minutes and 4 minutes), and then correlate these values with the CT result.

    Secondary Outcome Measures

    1. Vital capacity (the maximal amount of air that can be inhaled, measured in milliliters) during augmented pulse oximetry. [The single maximum value obtained before, during, or after use of the incentive spirometer.]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • 18 years of age or greater.

    • Agrees and able to participate in the study.

    • Room air SpO2 (oxygen saturation) less than 92% and newly-diagnosed PE (or controls with no PE) based on CT angiogram result.

    Exclusion Criteria:
    • Clinical concern for instability.

    • Systolic blood pressure less than 100 mm Hg.

    • Heart rate ≥140 beats per minute.

    • Oxygen saturation less than 85% with more than 4 L supplemental oxygen.

    • Unable to participate/comply with instructions for using the incentive spirometer.

    • Patients from the Federal Medical Center in Rochester, Minnesota.

    • Patients who do not speak English (due to the need for expediency).

    Patients will be under the care of the Emergency Department team who have the skills and resources to monitor and treat patients if they were to become unstable.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Mayo Clinic Rochester Minnesota United States 55905

    Sponsors and Collaborators

    • Mayo Clinic

    Investigators

    • Principal Investigator: A. S. Keller, MD, Mayo Clinic

    Study Documents (Full-Text)

    None provided.

    More Information

    Additional Information:

    Publications

    None provided.
    Responsible Party:
    Scott Keller, PI, Mayo Clinic
    ClinicalTrials.gov Identifier:
    NCT01898637
    Other Study ID Numbers:
    • 12-009527
    First Posted:
    Jul 12, 2013
    Last Update Posted:
    Feb 15, 2022
    Last Verified:
    Feb 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Scott Keller, PI, Mayo Clinic
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Feb 15, 2022